LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 116 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $98,000 | -37.2% | 21,454 | -19.2% | 0.01% | -45.5% |
| Q1 2021 | $156,000 | -53.0% | 26,560 | -84.4% | 0.01% | -57.7% |
| Q1 2020 | $332,000 | -63.0% | 170,500 | +19.6% | 0.03% | -50.9% |
| Q2 2019 | $897,000 | -5.8% | 142,600 | -16.7% | 0.05% | -1.9% |
| Q1 2019 | $952,000 | -7.2% | 171,246 | +10.8% | 0.05% | -5.3% |
| Q4 2018 | $1,026,000 | -54.0% | 154,501 | -26.1% | 0.06% | -38.7% |
| Q3 2018 | $2,230,000 | -22.0% | 208,999 | -12.3% | 0.09% | -14.7% |
| Q2 2018 | $2,860,000 | +40.7% | 238,299 | +0.5% | 0.11% | +58.0% |
| Q1 2018 | $2,033,000 | -13.6% | 237,200 | -0.4% | 0.07% | +1.5% |
| Q4 2017 | $2,352,000 | +1300.0% | 238,097 | +1042.2% | 0.07% | +1600.0% |
| Q2 2015 | $168,000 | – | 20,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |